Pulmonx Corporation (NASDAQ: LUNG) reported Q1 EPS of ($0.33), $0.02 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $22.65 million.

GUIDANCE:

Pulmonx Corporation sees FY2026 revenue of $90-92 million, versus the consensus of $90.9 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.